|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Signaling protein
|
 |
|
Title:
|
 |
Crystal structure of mouse neuroserpin (cleaved form)
|
|
Structure:
|
 |
Neuroserpin. Chain: a, b. Synonym: protease inhibitor 17. Engineered: yes. Neuroserpin. Chain: c, d. Synonym: protease inhibitor 17. Engineered: yes. Neuroserpin.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Gene: serpini1 or pi12 or spi17. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
3.06Å
|
R-factor:
|
0.232
|
R-free:
|
0.308
|
|
|
Authors:
|
 |
C.Briand,S.V.Kozlov,P.Sonderegger,M.G.Gruetter
|
Key ref:
|
 |
C.Briand
et al.
(2001).
Crystal structure of neuroserpin: a neuronal serpin involved in a conformational disease.
FEBS Lett,
505,
18-22.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Jul-01
|
Release date:
|
09-Jan-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
O35684
(NEUS_MOUSE) -
Neuroserpin from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
410 a.a.
40 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, C, E, B, D, F:
E.C.?
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
FEBS Lett
505:18-22
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of neuroserpin: a neuronal serpin involved in a conformational disease.
|
|
C.Briand,
S.V.Kozlov,
P.Sonderegger,
M.G.Grütter.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The protease inhibitor neuroserpin regulates the development of the nervous
system and its plasticity in the adult. Neuroserpins carrying the Ser53Pro or
Ser56Arg mutation form polymers in neuronal cells. We describe here the
structure of wild-type neuroserpin in a cleaved form. The structure provides a
basis to understand the role of the mutations in the polymerization process. We
propose that these mutations could delay the insertion of the reactive center
loop into the central beta-sheet A, an essential step in the inhibition and
possibly in the polymerization of neuroserpin.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Ser53 and Ser56 and the insertion of RCL: a model.
A: The ‘shutter region’ in the native form (in dark blue,
template α1-antitrypsin [27]). A ring of hydrogen bonds links
the side chain of Ser56, His334 and Asn186. B: After
preinsertion of the RCL (in green), His334 must rotate and
interact with the backbone C=O of Asn186. During the
preinsertion of the RCL, Val188 slides between Ser53 and Ser56 (
Fig. 4A), so Ser56 must also rotate. Consequently, Asn186 has to
rotate to maintain its interaction with Ser56 (antithrombin
structure used as a template [26]). C: Asn186 continues to slide
between residues 56 and 60 ( Fig. 4A). Its side chain rotates to
a similar position as seen in the native form. Ser351 takes the
place of Asn186 and the β-strand s3A translocates from its
preinserted position to its relaxed position (in orange;
structure of neuroserpin). The loss of the hydrogen bond between
Asn186 and His334 is compensated for by the formation of a
hydrogen bond with the OH side chain of Ser351. Prepared with
Setor [31].
|
 |
Figure 4.
Fig. 4. Effect of the two mutations on the RCL insertion
mechanism. A: During the preinsertion (β-strand s3A in blue
moved to the position in green) and the full insertion of the
RCL (β-strand s3A in orange) Val188 has to slide into groove 1
of α-helix hB (residues 53–56). Likewise, Asn186 has to slide
into groove 2 of α-helix hB (residues 56–60). B: Effect of
the Ser53Pro mutation. β-Strand s6A and α-helix hB of the
cleaved form are colored in orange. By adding a new hydrophobic
residue in the native form (in dark blue) and in the preinserted
form (in green), Val188 of β-strand s3A can make a hydrophobic
interaction with Pro53. After RCL insertion, a rearrangement in
the bottom part of β-strand s3A occurs, affecting the position
of Val188. Since this hydrophobic interaction must be disrupted
after preinsertion to fully insert the RCL, the rate of
insertion could be reduced. C: Effect of the Ser56Arg mutation.
Arg56 replaces Ser56, which normally swings during the insertion
of the reactive loop [28]. Conversely, in the native form and in
the preinserted form (here in green) the Nε side chain of Arg56
can hydrogen-bond the Oδ side chain of Asn186. The Nη1 or Nη2
side chain of Arg56 will also hydrogen-bond the Oδ side chain
of Asn94. Arg56 is at the place where Asn186 has to slide when
the loop is fully inserted. To fully insert the RCL, Arg56 must
lose its hydrogen bonds and shift into another position, that is
also slowing down the rate of the full insertion. Prepared with
Setor [31].
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the Federation of European Biochemical Societies:
FEBS Lett
(2001,
505,
18-22)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Gómez Ravetti,
O.A.Rosso,
R.Berretta,
and
P.Moscato
(2010).
Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.
|
| |
PLoS One,
5,
e10153.
|
 |
|
|
|
|
 |
A.Takasawa,
I.Kato,
K.Takasawa,
Y.Ishii,
T.Yoshida,
M.H.Shehata,
H.Kawaguchi,
O.M.Mohafez,
M.Sasahara,
and
K.Hiraga
(2008).
Mutation-, Aging-, and Gene Dosage-dependent Accumulation of Neuroserpin (G392E) in Endoplasmic Reticula and Lysosomes of Neurons in Transgenic Mice.
|
| |
J Biol Chem,
283,
35606-35613.
|
 |
|
|
|
|
 |
D.Belorgey,
P.Hägglöf,
S.Karlsson-Li,
and
D.A.Lomas
(2007).
Protein misfolding and the serpinopathies.
|
| |
Prion,
1,
15-20.
|
 |
|
|
|
|
 |
D.J.Askew,
S.Cataltepe,
V.Kumar,
C.Edwards,
S.M.Pace,
R.N.Howarth,
S.C.Pak,
Y.S.Askew,
D.Brömme,
C.J.Luke,
J.C.Whisstock,
and
G.A.Silverman
(2007).
SERPINB11 is a new noninhibitory intracellular serpin. Common single nucleotide polymorphisms in the scaffold impair conformational change.
|
| |
J Biol Chem,
282,
24948-24960.
|
 |
|
|
|
|
 |
A.Cuadrado,
C.Navarro-Yubero,
H.Furneaux,
J.Kinter,
P.Sonderegger,
and
A.Muñoz
(2002).
HuD binds to three AU-rich sequences in the 3'-UTR of neuroserpin mRNA and promotes the accumulation of neuroserpin mRNA and protein.
|
| |
Nucleic Acids Res,
30,
2202-2211.
|
 |
|
|
|
|
 |
D.Belorgey,
D.C.Crowther,
R.Mahadeva,
and
D.A.Lomas
(2002).
Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro.
|
| |
J Biol Chem,
277,
17367-17373.
|
 |
|
|
|
|
 |
R.L.Davis,
A.E.Shrimpton,
R.W.Carrell,
D.A.Lomas,
L.Gerhard,
B.Baumann,
D.A.Lawrence,
M.Yepes,
T.S.Kim,
B.Ghetti,
P.Piccardo,
M.Takao,
F.Lacbawan,
M.Muenke,
R.N.Sifers,
C.B.Bradshaw,
P.F.Kent,
G.H.Collins,
D.Larocca,
and
P.D.Holohan
(2002).
Association between conformational mutations in neuroserpin and onset and severity of dementia.
|
| |
Lancet,
359,
2242-2247.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |
|